Benralizumab monotherapy was insufficient to induce remission in patients with active eosinophilic granulomatosis with polyangiitis

Eosinophils play an important pathogenetic role in the development of eosinophilic granulomatosis with polyangiitis (EGPA). EGPA has long been treated with systemic corticosteroids and immunosuppressive agents. However, in recent years, biologic agents targeting eosinophils (anti-IL-5 antibody; mepo...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuno, Osamu, Minamoto, Seijiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637965/
https://www.ncbi.nlm.nih.gov/pubmed/36353062
http://dx.doi.org/10.1016/j.rmcr.2022.101763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637965/
https://www.ncbi.nlm.nih.gov/pubmed/36353062
http://dx.doi.org/10.1016/j.rmcr.2022.101763

Ejemplares similares